Skip to main content
. Author manuscript; available in PMC: 2016 Jul 21.
Published in final edited form as: Ann Emerg Med. 2015 Nov 6;67(2):240–248.e3. doi: 10.1016/j.annemergmed.2015.09.020

Table 3.

Interruptive nonopioid and opioid drug alerts: relative risk of override stratified by provider type and alert type in a random sample of 1 alert per patient visit.

n=1,576 Opioid Overrides, % (n) Nonopioid Overrides, % (n) Relative Risk 95% CI
Overall total 95.7 (628) 89.7 (818) 1.35 1.21–1.50
Provider type
 Pharmacist 97.6 (80) 89.4 (236) 1.25 1.11–1.40
 PA 97.0 (64) 89.2 (58) 1.64 1.10–2.43
 RN 90.7 (49) 98.6 (70) 0.28 0.05–1.71
 Physician 96.6 (200) 91.1 (164) 1.54 1.15–2.07
 Resident 94.8 (219) 87.3 (289) 1.37 1.16–1.61
 Other*  100 (2) 94.1 (16) 1.13 0.96–1.32
Alert type
 Duplicate therapy 98.6 (342) 94.3 (377) 1.57 1.30–1.89
 Duplicate med order 98.9 (93) 91.5 (246) 1.32 1.19–1.47
 Drug allergy 87.4 (153) 58.1 (68) 2.24 1.74–2.89
 Drug-drug interaction  100 (2) 97.6 (41) 1.05 0.98–1.12
 Lactation/pregnancy All alerts overridden; n=46 nonopioids, n=24 opioids
 Other All alerts overridden; n=57 nonopioids, n=3 opioids

PA, Physician assistant; RN, registered nurse.

*

“Other” includes anesthesiology assistants, technicians, medical students, and respiratory therapists.